AGEN: Agenus Inc. Stocks News on October 29, 2025

AGEN

Business Wire

12 days ago

Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025

AGEN

Business Wire

13 days ago

Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

AGEN

Zacks

4 months ago

Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

AGEN

Zacks

4 months ago

FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer

AGEN

Zacks

4 months ago

After Golden Cross, Agenus (AGEN)'s Technical Outlook is Bright

AGEN

MT Newswires

4 months ago

Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo

AGEN

Business Wire

4 months ago

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

AGEN

Insider Monkey

4 months ago

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion

AGEN

Zacks

4 months ago

SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion

AGEN

Business Wire

5 months ago

Agenus Announces Virtual Annual Shareholders Meeting

AGEN

MT Newswires

5 months ago

Agenus Shares Rise After Upgrade From HC Wainwright

AGEN

Zacks

5 months ago

Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade

AGEN

Pharmaceutical Technology

5 months ago

Agenus and Zydus sign agreements for botensilimab and balstilimab

AGEN

MT Newswires

5 months ago

HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target

AGEN

MT Newswires

5 months ago

Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences

AGEN

Business Wire

5 months ago

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

AGEN

Business Wire

5 months ago

Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer

AGEN

Zacks

5 months ago

Despite Fast-paced Momentum, Agenus (AGEN) Is Still a Bargain Stock

AGEN

Business Wire

5 months ago

Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025

AGEN

GuruFocus.com

6 months ago

Agenus Inc (AGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges

AGEN

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Agenus Inc Earnings Call

AGEN

Zacks

6 months ago

Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates

AGEN

Associated Press Finance

6 months ago

Agenus: Q1 Earnings Snapshot

AGEN

Business Wire

6 months ago

Agenus Reports Q1 2025 Financial Results and Key Business Updates

AGEN

Business Wire

6 months ago

Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer

AGEN

GuruFocus.com

6 months ago

Agenus Inc (AGEN) Q1 2025: Everything You Need To Know Ahead Of Earnings

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

AGEN

Zacks

6 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

AGEN

Zacks

6 months ago

Agenus (AGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

AGEN

Business Wire

6 months ago

Agenus to Provide Corporate Update and First Quarter 2025 Financial Report

AGEN

Business Wire

6 months ago

Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR

AGEN

Business Wire

6 months ago

Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025

AGEN

Business Wire

6 months ago

Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

AGEN

Zacks

6 months ago

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

AGEN

Business Wire

7 months ago

Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025

AGEN

Zacks

7 months ago

Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now

AGEN

Business Wire

7 months ago

Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation

AGEN

GuruFocus.com

8 months ago

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges

AGEN

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Agenus Inc Earnings Call

AGEN

Motley Fool

8 months ago

Agenus (AGEN) Q4 2024 Earnings Call Transcript

AGEN

Zacks

8 months ago

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates

AGEN

Associated Press Finance

8 months ago

Agenus: Q4 Earnings Snapshot

AGEN

Business Wire

8 months ago

Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

AGEN

Zacks

8 months ago

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

AGEN

Business Wire

8 months ago

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications

AGEN

Business Wire

8 months ago

Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

AGEN

Business Wire

8 months ago

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

AGEN

Business Wire

8 months ago

Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting

AGEN

Business Wire

8 months ago

CORRECTING and REPLACING Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

AGEN

Zacks

8 months ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates

AGEN

Zacks

8 months ago

Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates

AGEN

Zacks

9 months ago

Agenus (AGEN) Is Attractively Priced Despite Fast-paced Momentum

AGEN

Zacks

9 months ago

Are Medical Stocks Lagging Agenus (AGEN) This Year?

AGEN

Business Wire

9 months ago

Agenus Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas

AGEN

Business Wire

9 months ago

Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease

AGEN

Zacks

9 months ago

What Makes Agenus (AGEN) a New Buy Stock

AGEN

Zacks

9 months ago

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

AGEN

Business Wire

10 months ago

Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

AGEN

BioPharma Dive

a year ago

AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B

AGEN

Business Wire

a year ago

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs

AGEN

Benzinga

a year ago

Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development

AGEN

MT Newswires

a year ago

Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump

AGEN

Business Wire

a year ago

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment

AGEN

Zacks

a year ago

Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AGEN

Zacks

a year ago

Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AGEN

Zacks

a year ago

Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround

AGEN

Thomson Reuters StreetEvents

a year ago

Q3 2024 Agenus Inc Earnings Call

AGEN

GuruFocus.com

a year ago

Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...

AGEN

Motley Fool

a year ago

Agenus (AGEN) Q3 2024 Earnings Call Transcript

AGEN

Zacks

a year ago

Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates

AGEN

Associated Press Finance

a year ago

Agenus: Q3 Earnings Snapshot

AGEN

Business Wire

a year ago

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

AGEN

GuruFocus.com

a year ago

Earnings To Watch: Agenus Inc (AGEN) Reports Q3 2024 Result

AGEN

Business Wire

a year ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

AGEN

Business Wire

a year ago

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

AGEN

Business Wire

a year ago

Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024

AGEN

MT Newswires

a year ago

Agenus Sued by Shareholder for Misleading Investors Over Colorectal Cancer Immuno-Therapy Trial Results

AGEN

Business Wire

a year ago

Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024

AGEN

Business Wire

a year ago

Agenus to Participate in September Investor Conferences

AGEN

Motley Fool

a year ago

Agenus (AGEN) Q2 2024 Earnings Call Transcript

AGEN

Zacks

a year ago

Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates

AGEN

Associated Press Finance

a year ago

Agenus: Q2 Earnings Snapshot

AGEN

Business Wire

a year ago

Agenus Announces Appointment of Tom Harrison to Board of Directors

AGEN

Business Wire

a year ago

Agenus Reports Second Quarter 2024 Operational and Financial Results

AGEN

Business Wire

a year ago

Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers

AGEN

Benzinga

a year ago

Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus

AGEN

BioPharma Dive

a year ago

Bristol Myers sends TIGIT drug back to Agenus

AGEN

Zacks

a year ago

Agenus (AGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

AGEN

Zacks

a year ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

AGEN

Business Wire

a year ago

Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update

AGEN

Zacks

a year ago

Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

AGEN

BioPharma Dive

a year ago

Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug

AGEN

MT Newswires

a year ago

Agenus Says FDA Advised Against Accelerated Approval for Potential Colorectal Cancer Treatment; Shares Tumble

AGEN

Business Wire

a year ago

Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

AGEN

Zacks

a year ago

IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?

AGEN

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher in Afternoon Trading

AGEN

MT Newswires

a year ago

Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients

AGEN

Business Wire

a year ago

Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference

AGEN

Business Wire

a year ago

Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies

AGEN

Business Wire

a year ago

Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors

AGEN

Business Wire

a year ago

Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50

Latest Agenus Inc. (AGEN) News on October 29, 2025

Share on Social Networks: